RedHill Biopharma And Gaelan Medical Enter Into License Agreement For Talicia® For The United Arab Emirates

Business Affairs

RedHill Biopharma And Gaelan Medical Enter Into License Agreement For Talicia® For The United Arab Emirates

January 6, 2022

Published by
The Street

By PR Newswire RALEIGH, N.C. and TEL-AVIV, Israel, Jan. 6, 2022 /PRNewswire/ — RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company, announced that it has entered into an exclusive license agreement with Gaelan Medical Trade LLC (“Gaelan Medical”), a wholly owned subsidiary of the Ghassan Aboud Group (GAG), for Talicia® (omeprazole magnesium, amoxicillin and rifabutin) [1], an H. pylori therapy, in the United Arab Emirates (UAE). Under the terms of the agreement, RedHill will receive an upfront payment of $2 million and is eligible for add…

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages SSR Mining Inc. Investors to Secure Counsel Before Important May 17 Deadline in Securities Class Action First Filed by the Firm – SSRM

May 3, 2024

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Sonder Holdings Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – SOND

May 3, 2024

ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Rivian Automotive, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – RIVN

May 3, 2024

ROSEN, THE FIRST FILING FIRM, Encourages Sharecare, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – SHCR

May 3, 2024

ROSEN, THE FIRST FILING FIRM, Encourages Sharecare, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – SHCR

May 3, 2024

ROSEN, LEADING INVESTOR COUNSEL, Encourages Plug Power Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PLUG

May 3, 2024